Researchers at Hoag Memorial Hospital Presbyterian discovered a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma, an early precancerous stage of ovarian cancer. The breakthrough may enable detection years earlier, transforming ovarian cancer surveillance and prevention.
Surgeons agree that percutaneous needle biopsy is the best practice for initial diagnosis of breast abnormalities, offering equivalent accuracy and reduced risk of scarring. The procedure has been shown to provide detailed information about tumor characteristics, aiding in therapeutic decision-making before surgical intervention.
A study by Hoag Memorial Hospital Presbyterian found that patient-specific cancer vaccines derived from patients' own cells resulted in impressive long-term survival rates. The vaccine was well-tolerated, and eight patients experienced remarkable progression-free survival despite having widely metastatic disease.